logo
4-year-old girl facing deportation could die within days of losing medical care

4-year-old girl facing deportation could die within days of losing medical care

Miami Herald28-05-2025
Deysi Vargas' daughter was nearly 2 1/2 when she took her first steps.
The girl was a year delayed because she had spent most of her short life in a hospital in Playa del Carmen, Mexico, tethered to feeding tubes 24 hours a day. She has short bowel syndrome, a rare condition that prevents her body from completely absorbing the nutrients of regular food.
Vargas and her husband were desperate to get their daughter, whom the Los Angeles Times is identifying by her initials, S.G.V., better medical care. In 2023, they received temporary humanitarian permission to enter the U.S. legally through Tijuana.
Now in Bakersfield, California, the family received notice last month that their legal status had been terminated. The letter warned them: "It is in your best interest to avoid deportation and leave the United States of your own accord."
But doing so would put S.G.V., now a bubbly 4-year-old, at immediate risk of death.
"This is a textbook example of medical need," said the family's attorney, Rebecca Brown, of the pro bono legal firm Public Counsel. "This child will die and there's no sense for that to happen. It would just be a cruel sacrifice."
A spokesperson for U.S. Citizenship and Immigration Services declined to comment.
Children's Hospital Los Angeles, where the girl regularly receives treatment, declined to comment. But in a letter requested by the family, Dr. John Arsenault of CHLA wrote that he sees the girl every six weeks.
If there is an interruption in her daily nutrition system, called Total Parenteral Nutrition (TPN), the doctor wrote, "this could be fatal within a matter of days."
"As such, patients on home TPN are not allowed to leave the country because the infrastructure to provide TPN or provide immediate intervention if there is a problem with IV access depends on our program's utilization of U.S.-based healthcare resources and does not transfer across borders," Arsenault wrote.
Vargas, 28, is from the Mexican state of Oaxaca; her husband, 34, is from Colombia. They met in Cancun, where they were working. Just before S.G.V. was born, the couple moved to nearby Playa del Carmen so her husband could work as an Uber driver.
The girl was born a month premature and quickly taken to intensive care. After doctors discovered her condition, she underwent six surgeries to fix an intestinal blockage. But Vargas said the doctors cut out too much, and the girl was left with short bowels. She experienced repeated blood infections, including one that nearly killed her.
The girl's weight fluctuated severely. One month, she would look emaciated, her tiny limbs and bulging stomach incongruous with the family's relative access to resources. Another month, she was as round-cheeked as any other baby.
When S.G.V. was 7 months old, a doctor suggested that the family relocate to Mexico City, where pediatric care for short bowel syndrome was the best in the country. But although her condition initially improved, the blood infections continued.
Unable to work, Vargas spent all day, every day, at the hospital with her daughter. Some days, she said, nurses would mistakenly administer the wrong medication to S.G.V. Other days, Vargas would arrive to find that her daughter had thrown up on herself overnight and no one had cleaned her up.
Vargas tried to keep a watchful eye over her daughter. Even so, she said a nurse once mistakenly sped up S.G.V.'s nutrition system, causing her to quickly pee it out. The girl became dehydrated and her glucose levels skyrocketed before doctors whisked her to intensive care, where her condition stabilized.
Vargas had read about children similar to her daughter going on to have normal lives in other countries. In Mexico, her daughter was being kept alive - but at 2, her condition had not improved.
So when Vargas learned that the Biden administration had begun offering migrants appointments with border agents through a phone application called CBP One, she signed up. Those let in received two-year protection from deportation and work permits.
With the appointment set for July 31, 2023, Vargas and her family set out for Tijuana two days earlier. She carefully carried her daughter out of the hospital, her nutrition bags still connected intravenously.
Her husband told agents that he had once been kidnapped by cartel members in Mexico who extorted money and threatened to kill him. They also looked at the girl, whose vulnerable condition was obvious.
"God knew she needed better treatment," Vargas said. "When we got to the entrance, they saw her and asked us if we needed medical help."
By that afternoon, the family had been whisked to Rady Children's Hospital-San Diego.
S.G.V. quickly improved. Although she once was hooked up 24 hours a day to the feeding system that delivered nutrients directly into the bloodstream, doctors began weaning her off as her intestines got stronger.
A year later, doctors referred her to Children's Hospital Los Angeles, which has one of the top-ranked gastroenterology programs in the country.
Both of her parents worked, holding down odd jobs, and by September 2024, the family had settled in Bakersfield and S.G.V. was discharged from the hospital.
For the first time, S.G.V. experienced the outside world. At Walmart, her eyes widened from the shopping cart and she and her mom strolled the aisles.
"It was incredible," Vargas said. "I had waited so long for doctors to tell me, 'Ma'am, your daughter is OK now. She can go home.'"
Now, the girl spends 14 hours each night hooked up to the intravenous feeding system. She wears a backpack to take it on the go.
Four times a day, for an hour, her mom administers a different type of nutrition that goes straight into her stomach through a gastric tube. When the girl goes to preschool, she takes a larger backpack containing the milky fluid, and the school nurse administers her noon feeding.
Before S.G.V. takes a shower, Vargas unplugs her IV tubes, flushes them with saline and tapes a plastic sheet over her chest to keep water from getting in and infecting the area.
On a recent morning, Vargas dressed the girl in pink leggings, a Hello Kitty T-shirt and black Puma sneakers. As they left hand-in-hand for preschool, S.G.V.'s curly black hair was still wet and the adult-size backpack dangled behind her knees as she walked.
S.G.V.'s care is covered through Medi-Cal. But life in the U.S. isn't cheap.
Their modest living room contains little more than a hot plate on a folding table, a mini-fridge, a single chair and an IV bag stand. With no full kitchen, Vargas mostly makes sandwiches or soups. The fridge is filled with S.G.V.'s nutrition packs.
Vargas recently found steady work cleaning a restaurant. Finally, she thought, the family was achieving a sense of stability.
Then in April she received the notice from immigration authorities. This month, she received a notice terminating her employment authorization.
Vargas said she and her husband sometimes eat just once a day after paying rent and utilities, as well as for diapers and other necessities. Her husband is currently unemployed because of an injury, and she fears that losing her income could leave them homeless.
The thought of being forced by immigration agents to return to Mexico terrifies Vargas.
"I know the treatment they have there for her is not adequate, because we already lived it," she said. "Those were bad times. Here she is living the most normal life possible."
If not for her daughter's medical condition, Vargas said, they probably would still be in Mexico. They want to stay only for as long as the girl needs treatment. Exactly how long that could be is unclear, but the couple are hopeful that their child's condition will improve enough that she stops requiring supplemental nutrition.
Brown, their lawyer, submitted a petition for a continuation of their temporary humanitarian legal status based on S.G.V.'s medical condition. She believes the family's legal status was prematurely terminated by mistake.
President Donald Trump lambasted Biden over his broad expansion of programs allowing humanitarian entry, known as parole. On his first day in office, Trump issued an executive order to ensure that the discretionary authority be "exercised on only a case-by-case basis" for urgent humanitarian reasons or a significant public benefit.
"This is the intended purpose - to help the most vulnerable who need attention here," Brown said. "We can avoid having harmed the child and the family."
Although Trump said on the campaign trail that he would target criminals for deportation, his administration quickly began revoking the legal status of immigrants who have no criminal history.
The Trump administration has stripped humanitarian protections from hundreds of thousands of immigrants who entered the U.S. under various Biden-era programs. Thousands of people who similarly entered the country using the CBP One app received notices from the federal government around the same time Vargas did, ordering them to leave voluntarily or face criminal prosecution and other legal actions.
The same phone app that Vargas used to enter the country has since been turned into CBP Home, to help immigrants such as her self-deport. If not, the notice says, "the federal government will find you."
-----------
-Times staff photographer Myung J. Chun in Bakersfield contributed to this report.
Copyright (C) 2025, Tribune Content Agency, LLC. Portions copyrighted by the respective providers.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Mexican ranchers struggle to adapt as a tiny parasite ravages their cattle exports to the US
Mexican ranchers struggle to adapt as a tiny parasite ravages their cattle exports to the US

Chicago Tribune

time2 hours ago

  • Chicago Tribune

Mexican ranchers struggle to adapt as a tiny parasite ravages their cattle exports to the US

HERMOSILLO, Mexico — The United States' suspension of live cattle imports from Mexico hit at the worst possible time for rancher Martín Ibarra Vargas, who after two years of severe drought had hoped to put his family on better footing selling his calves across the northern border. Like his father and grandfather before him, Ibarra Vargas has raised cattle on the parched soil of Sonora, the state in northwestern Mexico that shares a long border with the United States, particularly Arizona. His family has faced punishing droughts before but has never before had to contend with the economic hit of a new scourge: the New World Screwworm, a flesh-eating parasite. U.S. agriculture officials halted live cattle crossing the border in July – the third suspension of the past eight months — due to concerns about the flesh-eating maggot which has been found in southern Mexico and is creeping north. The screwworm is a larva of the Cochliomyia hominivorax fly that can invade the tissues of any warm-blooded animal, including humans. The parasite enters animals' skin, causing severe damage and lesions that can be fatal. Infected animals are a serious threat to herds. The U.S. Department of Agriculture calls it a 'devastating pest' and said in June that it poses a threat to 'our livestock industry, our economy, and our food supply chain.' It has embarked on other steps to keep it out of the United States, which eradicated it decades ago. As part of its strategy the U.S. is preparing to breed billions of sterile flies and release them in Mexico and southern Texas. The aim is for the sterile males to mate with females in the wild who then produce no offspring. The U.S. ban on live cattle also applies to horses and bison imports. It hit a ranching sector already weakened by drought and specifically a cattle export business that generated $1.2 billion for Mexico last year. This year, Mexican ranchers have exported fewer than 200,000 head of cattle, which is less than half what they historically send in the same period. For Ibarra Vargas, considered a comparatively small rancher by Sonora's beef-centric standards, the inability to send his calves across the border has made him rethink everything. The repeated bans on Mexican cows by U.S. authorities has pushed his family to branch into beekeeping, raising sheep and selling cow's milk. What he earns is just a fraction of what he earned by exporting live cattle, but he is trying to hold on through the lean times. 'Tiempos de vacas flacas' — times of the lean cows — as he calls them. 'At least it lets us continue' ranching, the 57-year-old said with a white cowboy hat perched on his head. Even as ranchers in Sonora intensify their efforts to make sure the parasitic fly never makes it into their state, they've had to seek new markets. In the past two months, they've sold more than 35,000 mature cows within Mexico at a significant loss. 'We couldn't wait any longer,' said Juan Carlos Ochoa, president of the Sonora Regional Cattle Union. Those sales, he said, came at a '35% lower price difference compared with the export value of a cow.' That's hard to stomach when beef prices in the U.S. are rising. The U.S. first suspended cattle imports last November. Since then, more than 2,258 cases of screwworm have been identified in Mexico. Treatment requires a mix of manually removing the maggots, healing the lesions on the cows and using anti-parasite medicine. Some ranchers have also started retail beef sales through luxury butcher shops referred to as 'meat boutiques.' There are other foreign markets, for example Japan, but selling vacuum sealed steaks across the Pacific is a dramatically different business than driving calves to U.S. feedlots. The switch is not easy. With his calves mooing as they ran from one end of a small corral to the other waiting to be fed, Ibarra Vargas said he still hasn't figured out how he will survive an extended period of not being able to send them to the U.S. The recent two-year drought reduced his cattle stocks and forced him to take on debt to save the small family ranch that has survived for three generations. Juan Carlos Anaya, director of Agricultural Markets Consulting Group, attributed a 2% drop in Mexico's cattle inventory last year to the drought. Anaya said Mexican ranchers who export are trying to get the U.S. to separate what happens in southern Mexico from the cattle exporting states in the north where stricter health and sanitation measures are taken, 'but the damage is already done.' 'We're running out of time,' said Ibarra Vargas, who already laments that his children are not interested in carrying on the family business. For a rancher who 'doesn't have a market or money to continue feeding his calves, it's a question of time before he says: 'you know what, this is as far as I go.''

Mexico Microcarrier Market Trends and Company Analysis Report 2025-2033 Featuring BD, Thermo Fisher Scientific, Merck, Eppendorf, Danaher, Sartorius, Bio Rad, Corning, Lonza Group, Getinge
Mexico Microcarrier Market Trends and Company Analysis Report 2025-2033 Featuring BD, Thermo Fisher Scientific, Merck, Eppendorf, Danaher, Sartorius, Bio Rad, Corning, Lonza Group, Getinge

Yahoo

timea day ago

  • Yahoo

Mexico Microcarrier Market Trends and Company Analysis Report 2025-2033 Featuring BD, Thermo Fisher Scientific, Merck, Eppendorf, Danaher, Sartorius, Bio Rad, Corning, Lonza Group, Getinge

The Mexico Microcarrier Market is poised for significant growth, projected to reach US$ 77.65 million by 2033 from US$ 39.96 million in 2024, achieving a CAGR of 7.66% from 2025 to 2033. Key drivers include increased investment in regenerative medicine and cell therapy, rising demand for cell-based vaccines and biologics, and technological advancements in cell culture efficiency. Mexico's biopharmaceutical sector expansion, supported by enhanced bioprocessing infrastructure and strategic public-private partnerships, further bolsters this growth. Emerging challenges include high setup costs and complex regulatory requirements, offering opportunities for innovation and collaboration. Mexican Microcarrier Market Dublin, Aug. 13, 2025 (GLOBE NEWSWIRE) -- The "Mexico Microcarrier Market to Reach US$ 77.65 Million by 2033 - 7.66% CAGR Growth Driven by Biopharma Demand" report has been added to Mexico Microcarrier Market is expected to reach US$ 77.65 million by 2033 from US$ 39.96 million in 2024, with a CAGR of 7.66% from 2025 to 2033. Growing investment in regenerative medicine and cell therapy, growing demand for cell-based vaccines and biologics, technological advancements in culture efficiency, and expansion of biopharmaceutical research and development in Mexico. Mexico's growing biopharmaceutical and biotechnology industries depend heavily on the microcarrier industry. The large-scale manufacturing of biologics, vaccines, and cell treatments depends on microcarriers, which are tiny, spherical particles that promote the proliferation of adherent cells in bioreactors. As Mexico looks to improve its local manufacturing capabilities in response to growing healthcare demands and the need for medical product self-sufficiency, these applications become more and more market is expanding due to a number of causes. Research and development expenditures, along with the nation's strategic efforts to strengthen its biomanufacturing infrastructure, are essential. The need for effective cell culture systems is further fueled by the aging population and the rising incidence of chronic diseases, which increase demand for cutting-edge treatment solutions. Additionally, Mexico has easier access to cutting-edge biotechnologies, such as microcarrier-based cell culture systems, thanks to its involvement in international health programs and collaborations with foreign the encouraging growth trajectory, the Mexican microcarrier market still confronts obstacles including the requirement for specialized technological know-how and the development of strong regulatory frameworks to guarantee the quality and safety of the products. Nonetheless, these difficulties offer chances for creativity and cooperation. These problems can be resolved by creating training initiatives, establishing regulatory guidelines, and encouraging public-private partnerships. This will create an atmosphere that is favorable for the expansion of the microcarrier market and the larger biopharmaceutical sector in Factors Driving the Mexico Microcarrier Market Growth Increasing Demand for Cell Therapy and BiopharmaceuticalsMicrocarrier systems are in high demand due to Mexico's growing biopharmaceutical industry, which includes the manufacture of vaccines, biologics, and cell treatments. Businesses are depending more and more on microcarriers to sustain high density adherent cell cultures in bioreactors as local R&D becomes more intense and manufacturing capacity need is particularly noticeable in the creation of therapeutic proteins, monoclonal antibodies, and items related to regenerative medicine. Scalable and effective cell culture is made possible by microcarriers, which is necessary for the commercial production of biologics and sophisticated cell culture systems are now a vital enabling technology for Mexico's biomanufacturing efforts as the nation develops its capacities in these fields and aligns with international health Development and Manufacturing ExpansionMexico's bioprocessing infrastructure is being quickly strengthened through government sponsored initiatives and strategic public-private partnerships. The adoption of effective cell culture technologies is being fueled by investments in upstream bioprocessing facilities, automation, single use systems, and digital technology is also supported by the growth of industry academia partnership and regulatory modernization (e.g., COFEPRIS's digital transformation). These advancements promote easier technology transfer from research to production and improve the technical preparedness required for microcarrier is therefore better able to scale complex bioprocesses, which increases the accessibility of microcarriers for biotechnology companies, contract manufacturers, and academic institutions seeking to increase their capacity for and Technological Progress in MicrocarriersPerformance and scalability have been greatly enhanced by innovations in microcarrier design, such as surface functionalized beads, biodegradable materials, and compatibility with single use bioreactors. Manufacturers who prioritize quality and cost effectiveness are placing a greater value on enhanced features like increased yield, better cell adhesion, and lower contamination developments, when combined with automation, intelligent sensor integration, and digital process control, reduce human error and streamline production. Modern microcarrier formats are becoming feasible choices for biomanufacturers and researchers nation wide due to Mexico's rising alignment with international industry trends and the country's expanding adoption of state of the art bioprocessing in the Mexico Microcarrier Market Expensive Startup and Ongoing CostsMicrocarrier based cell culture system deployment requires a large financial outlay, especially for equipment such as bioreactors, single use systems, and associated infrastructure. Traditional planar culture techniques are still less expensive at lower scales because they require less like microcarrier beads make up a significant portion of the continuous expenses for microcarrier setups, which frequently require tens or even hundreds of thousands of dollars in capital expenditure. GMP grade, high quality microcarriers can account for 20-25% of total consumable financial barriers, in addition to media supplies and labor training, make the technology hard to adopt in Mexico, where a large number of biotech companies and academic institutions have tight budgets. Despite the long term productivity and efficiency benefits of microcarriers, this hinders scale of Regulations and Documentation NeedsUnder the General Health Law, COFEPRIS is in charge of regulating microcarrier based cell culture in Mexico, particularly when it is meant for clinical or therapeutic applications. In accordance with ICH guidelines, businesses are required to compile comprehensive Common Technical Document (CTD) dossiers that include clinical, non clinical, and quality is necessary to adhere to Official Mexican Standards (such as NOM?257?SSA1?2014, NOM?059?SSA1?2015), especially those that deal with GMP, bio comparability, and safety assessment. Microcarrier systems need to be thoroughly validated, which includes testing for batch uniformity, sterility, and cell material obstacles to commercialization include the burden of complicated documentation and testing, changing regulations, and unclear advanced therapeutic standards. Market access may be delayed, more expensive, and unclear for entities without local regulatory partnerships or past dossier experience. Company Analysis: Overview, Key Persons, Recent Developments, SWOT Analysis, Revenue Analysis Thermo Fisher Scientific Merck KGaA Eppendorf AG Danaher Corporation Sartorius AG Bio Rad Laboratories, Inc. Corning Inc. Lonza Group Getinge Becton, Dickinson and Company Key Attributes: Report Attribute Details No. of Pages 200 Forecast Period 2024 - 2033 Estimated Market Value (USD) in 2024 $39.96 Million Forecasted Market Value (USD) by 2033 $77.65 Million Compound Annual Growth Rate 7.6% Regions Covered Mexico Key Topics Covered: 1. Introduction2. Research & Methodology2.1 Data Source2.1.1 Primary Sources2.1.2 Secondary Sources2.2 Research Approach2.2.1 Top-Down Approach2.2.2 Bottom-Up Approach2.3 Forecast Projection Methodology3. Executive Summary4. Market Dynamics4.1 Growth Drivers4.2 Challenges5. Mexico Microcarrier Market5.1 Historical Market Trends5.2 Market Forecast6. Market Share Analysis6.1 By Product Type6.2 By Application6.3 By End User6.4 By Region7. Product Type7.1 Consumables7.1.1 Microcarrier Beads7.1.2 Media & Reagents7.2 Equipment8. Application8.1 Cell Therapy8.1.1 Market Analysis8.1.2 Market Size & Forecast8.2 Vaccine Manufacturing8.3 Others9. End User9.1 Pharmaceutical & Biotechnology Companies9.2 Contract Research Organizations & Contract Manufacturing Organizations9.3 Academic & Research Institutes10. Region10.1 Northern Mexico10.2 Central Mexico10.3 Southern Mexico10.4 Others11. Value Chain Analysis12. Porter's Five Forces Analysis12.1 Bargaining Power of Buyers12.2 Bargaining Power of Suppliers12.3 Degree of Competition12.4 Threat of New Entrants12.5 Threat of Substitutes13. SWOT Analysis13.1 Strength13.2 Weakness13.3 Opportunity13.4 Threats14. Pricing Benchmark Analysis14.1 Thermo Fisher Scientific14.2 Merck KGaA14.3 Eppendorf AG14.4 Danaher Corporation14.5 Sartorius AG14.6 Bio-Rad Laboratories, Inc.14.7 Corning Inc.14.8 Lonza Group14.9 Getinge14.10 Becton, Dickinson and Company15. Key Players Analysis For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Mexican Microcarrier Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Wild Pigs in California Are Turning Neon Blue on the Inside, Officials Warn
Wild Pigs in California Are Turning Neon Blue on the Inside, Officials Warn

Gizmodo

time5 days ago

  • Gizmodo

Wild Pigs in California Are Turning Neon Blue on the Inside, Officials Warn

Unexpected exposure to rodenticide is turning California's wild pigs blue, state authorities say. 'I'm not talking about a little blue,' Dan Burton, owner of a wildlife control company in Salinas, California, told The Los Angeles Times. 'I'm talking about neon blue, blueberry blue.' Burton was one of the first trappers to discover that local wild pigs had turned blue on the inside. A subsequent investigation by the California Department of Fish and Wildlife (CDFW) found that the pigs had consumed the anticoagulant rodenticide diphacinone, a poison used by farmers to control populations of unwanted rats, mice, squirrels, and other small animals. These substances often contain dye to identify them as poison, the CDFW reported, which likely explains how the pigs ended up with blue-colored muscle and fat. Burton's own investigations found that the poisoned pigs seemed to be frequenting squirrel bait stations, which local farmers were using to control the squirrel populations targeting their crops. However, since the poisoned bait had tiny doses of diphacinone, the pigs, despite turning blue, weren't outwardly acting sick. Eating animals poisoned by this rodenticide could result in secondary exposure to the poison, the CDFW said. As such, the agency is warning hunters to not consume any wild animals with signs of blue contamination and to report any sightings of such animals to officials. Overall, the agency advised hunters to exercise extra caution around areas with rat control programs, as it is also possible that exposed animals may not necessarily be blue. 'Hunters should be aware that the meat of game animals, such as wild pig, deer, bear and geese, might be contaminated if that game animal has been exposed to rodenticides,' said Ryan Bourbor, pesticide investigations coordinator at CDFW, in the statement. This isn't the first time that officials have identified wild pigs poisoned by rat poison. In 2018, a study by the CDFW found traces of rodenticide in about 8.3% of wild pigs spotted lurking around agricultural or residential areas with rat control programs. Other research from 2011 and 2023, respectively, found that cooking meat poisoned with diphacinone did not eliminate the contamination, and people and animals that consume the meat can exhibit signs of rodenticide poisoning, such as lethargy. In 2024, California prohibited the use of diphacinone, with exceptions for specific instances at certified sites, as part of legislation meant to protect wildlife from unintentional poisoning. CDFW is asking anyone who encounters wild animals with blue fat or tissues to report their sightings to the agency at [email protected] or (916) 358-2790.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store